New York Life Investment Management LLC Pacira Bio Sciences, Inc. Transaction History

New York Life Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$27.7 - $35.48 $110,246 - $141,210	3,980 Added 46.68%	12,507 $365,000
Q4 2023 Feb 05, 2024	SELL	$26.32 - $34.31 $5,185 - $6,759	-197 Reduced 2.26%	8,527 $287,000
Q3 2023 Nov 07, 2023	SELL	$30.68 - $40.09 $42,185 - $55,123	-1,375 Reduced 13.62%	8,724 $267,000
Q2 2023 Aug 04, 2023	SELL	$36.12 - $47.5 $53,746 - $70,680	-1,488 Reduced 12.84%	10,099 $404,000
Q1 2023 May 08, 2023	BUY	$35.53 - $43.38 $411,686 - $502,644	11,587 New	11,587 $472,000

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.06B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.